This company has been marked as potentially delisted and may not be actively trading. Cleveland BioLabs (CBLI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CBLI vs. SCPS, VAXX, CALA, CMRA, ARDS, STAB, AMPE, CLVR, MTEM, and ONCSQShould you be buying Cleveland BioLabs stock or one of its competitors? The main competitors of Cleveland BioLabs include Scopus BioPharma (SCPS), Vaxxinity (VAXX), Calithera Biosciences (CALA), Comera Life Sciences (CMRA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), Clever Leaves (CLVR), Molecular Templates (MTEM), and OncoSec Medical (ONCSQ). These companies are all part of the "medical" sector. Cleveland BioLabs vs. Scopus BioPharma Vaxxinity Calithera Biosciences Comera Life Sciences Aridis Pharmaceuticals Statera Biopharma Ampio Pharmaceuticals Clever Leaves Molecular Templates OncoSec Medical Cleveland BioLabs (NASDAQ:CBLI) and Scopus BioPharma (NASDAQ:SCPS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership, dividends, valuation and risk. Does the media favor CBLI or SCPS? In the previous week, Cleveland BioLabs' average media sentiment score of 0.00 equaled Scopus BioPharma'saverage media sentiment score. Company Overall Sentiment Cleveland BioLabs Neutral Scopus BioPharma Neutral Which has more volatility & risk, CBLI or SCPS? Cleveland BioLabs has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Comparatively, Scopus BioPharma has a beta of -0.29, meaning that its stock price is 129% less volatile than the S&P 500. Does the MarketBeat Community believe in CBLI or SCPS? Cleveland BioLabs received 274 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 54.55% of users gave Cleveland BioLabs an outperform vote. CompanyUnderperformOutperformCleveland BioLabsOutperform Votes27654.55% Underperform Votes23045.45% Scopus BioPharmaOutperform Votes2100.00% Underperform VotesNo Votes Is CBLI or SCPS more profitable? Scopus BioPharma's return on equity of 0.00% beat Cleveland BioLabs' return on equity.Company Net Margins Return on Equity Return on Assets Cleveland BioLabsN/A -32.84% -31.29% Scopus BioPharma N/A N/A N/A Which has better earnings & valuation, CBLI or SCPS? Cleveland BioLabs has higher revenue and earnings than Scopus BioPharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCleveland BioLabs$260K0.00-$2.40MN/AN/AScopus BioPharmaN/AN/A-$11.61MN/AN/A Do institutionals and insiders hold more shares of CBLI or SCPS? 5.1% of Cleveland BioLabs shares are owned by institutional investors. 1.0% of Cleveland BioLabs shares are owned by insiders. Comparatively, 5.1% of Scopus BioPharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryCleveland BioLabs beats Scopus BioPharma on 5 of the 9 factors compared between the two stocks. Get Cleveland BioLabs News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart CBLI vs. The Competition Export to ExcelMetricCleveland BioLabsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$5,000.00$6.70B$5.50B$8.59BDividend YieldN/A2.57%5.25%4.17%P/E RatioN/A8.5227.1320.04Price / SalesN/A254.69415.94161.86Price / CashN/A65.8538.2534.64Price / BookN/A6.596.974.69Net Income-$2.40M$143.49M$3.23B$247.88M Cleveland BioLabs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLICleveland BioLabsN/AN/AN/AN/A$5,000.00$260,000.000.004SCPSScopus BioPharmaN/A$0.00flatN/AN/A$13,000.00N/A0.009VAXXVaxxinityN/A$0.00-99.0%N/A-88.8%$13,000.00N/A0.0090Gap UpCALACalithera Biosciences0.5919 of 5 stars$0.00-47.4%N/AN/A$10,000.00N/A0.0060Gap DownCMRAComera Life SciencesN/A$0.00flatN/AN/A$6,000.00$1.00M0.002ARDSAridis PharmaceuticalsN/A$0.00-66.7%N/A-99.8%$5,000.00$3.09M0.0030Gap DownSTABStatera BiopharmaN/A$0.00flatN/A-83.3%$5,000.00N/A0.0020AMPEAmpio Pharmaceuticals0.2075 of 5 stars$0.00flatN/A-13.0%$3,000.00N/A0.0020CLVRClever LeavesN/A$0.00flatN/A-100.0%$1,000.00$17.42M0.00560MTEMMolecular TemplatesN/AN/AN/AN/A$1,000.00$23.48M0.00260ONCSQOncoSec MedicalN/AN/AN/AN/A$1,000.00N/A0.0040 Related Companies and Tools Related Companies Scopus BioPharma Alternatives Vaxxinity Alternatives Calithera Biosciences Alternatives Comera Life Sciences Alternatives Aridis Pharmaceuticals Alternatives Statera Biopharma Alternatives Ampio Pharmaceuticals Alternatives Clever Leaves Alternatives Molecular Templates Alternatives OncoSec Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLI) was last updated on 6/7/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cleveland BioLabs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cleveland BioLabs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CBLI Stock Free CBLI Stock Alerts